Infectious Disease

  • Bertozzi’s chemistry expertise advances research into cancer immunotherapies, tumor biology and COVID-19.

  • What to know about polio

    The first polio case in the U.S. since 2013 emerged in July, and cases have increased abroad. Yvonne Maldonado answers questions about the virus and its impacts.

  • Antivirals may benefit some inpatients

    Elevated virus levels in hospitalized COVID-19 patients’ blood predicts worsening respiratory symptoms and suggests ongoing viral replication in later disease stages, Stanford Medicine-led study says.

  • COVID-19 virus can infect fat tissue

    Stanford Medicine scientists’ findings could explain why obese people have a higher risk of SARS-CoV-2 infection and are more likely to progress to severe disease and die of infection.

  • What to know about mpox

    The mpox virus is normally endemic to Africa but has recently been found on other continents. It spreads through prolonged, direct contact with infected people or their bedding, clothing and towels.

  • Viral genome packing key in replication

    Disrupting a virus’s genome packaging can halt replication and jumpstart a natural immune response against subsequent exposures, a Stanford Medicine study finds.

  • Mark Davis on immunology research

    Vaccinology has taken great leaps forward in the past decade, largely due to advanced analytical methods as well as a shift in researchers’ focus from rodents to humans.

  • Hints into long COVID

    People with lower levels of an antiviral antibody as well as those with lung disease take longer to clear COVID-19 symptoms, say Stanford Medicine researchers.

  • Gummy phlegm and COVID-19

    Levels of a stringy, spongy substance soar in the sputum of COVID-19 patients requiring intubation, accounting for at least some of their breathing trouble. Development of an off-patent drug may prevent it.

  • Stanford Medicine provides mpox test

    Stanford Medicine now provides a test for the mpox virus. Rapid identification of infected people will help combat the virus’s spread and facilitate patient care.

  • COVID vaccine approved for young kids

    Children as young as 6 months can now receive the Pfizer BioNTech and Moderna mRNA vaccines.

  • 1,000+genes linked to severe COVID-19

    Using machine learning, researchers from Stanford Medicine and their collaborators found specific genetic signals in people who develop severe coronavirus infection.


Related Websites